Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001178913-26-000330·Harel Insurance Investments & Financial Services Ltd.
Schedule 13G ownership disclosure
TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares, par value NIS 0.10 per share · CUSIP: M8769Q102
Event date: 2025-12-31
- Filing-level shares
- 72,325,555
- Percent of class
- 6.3%
- Harel Insurance Investments & Financial Services Ltd
Shares: 72,325,555 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-26-000330
- Form type
- SCHEDULE 13G/A
- Filer
- Harel Insurance Investments & Financial Services Ltd.
- CIK
- CIK 1429390
- Filed
- Feb 09, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership